Content area
Abstract
To establish and validate a droplet digital PCR (ddPCR) assay for quantifying FRS2 gene copy number in formalin-fixed paraffin-embedded (FFPE) bladder cancer tissue samples, and to evaluate its analytical performance.
OBJECTIVE
To establish and validate a droplet digital PCR (ddPCR) assay for quantifying FRS2 gene copy number in formalin-fixed paraffin-embedded (FFPE) bladder cancer tissue samples, and to evaluate its analytical performance.The ddPCR assay was developed using FRS2 as the target gene and RPP30 as the reference gene. Artificial plasmids, genomic DNA from urinary sediment of healthy individuals and cell lines were used as templates to assess the assay's precision, minimum reliable input DNA, and linearity. Fluorescence in situ hybridization (FISH) was employed to validate the accuracy of the ddPCR results.METHODS
The ddPCR assay was developed using FRS2 as the target gene and RPP30 as the reference gene. Artificial plasmids, genomic DNA from urinary sediment of healthy individuals and cell lines were used as templates to assess the assay's precision, minimum reliable input DNA, and linearity. Fluorescence in situ hybridization (FISH) was employed to validate the accuracy of the ddPCR results.One-dimensional fluorescence amplitude plots showed clear separation between positive and negative droplets for both FRS2 and RPP30. Duplex detection of FRS2 and RPP30 within the same reaction showed no interference between primers or probes. The assay exhibited excellent repeatability and precision, with intra-assay coefficient of variation (CV)% of 2.58% and 3.75%, and inter-assay CV% of 2.68% and 3.79%, across 20 ng and 2 ng input levels, respectively. The minimum reliable input DNA amount was determined to be 2 ng, and a strong linear relationship was observed (R2 >0.99). Compared to FISH, the ddPCR assay showed 100% sensitivity, 100% specificity, and a kappa value of 1.RESULTS
One-dimensional fluorescence amplitude plots showed clear separation between positive and negative droplets for both FRS2 and RPP30. Duplex detection of FRS2 and RPP30 within the same reaction showed no interference between primers or probes. The assay exhibited excellent repeatability and precision, with intra-assay coefficient of variation (CV)% of 2.58% and 3.75%, and inter-assay CV% of 2.68% and 3.79%, across 20 ng and 2 ng input levels, respectively. The minimum reliable input DNA amount was determined to be 2 ng, and a strong linear relationship was observed (R2 >0.99). Compared to FISH, the ddPCR assay showed 100% sensitivity, 100% specificity, and a kappa value of 1.The developed ddPCR assay enables accurate and reliable quantification of FRS2 copy number in FFPE samples, offering a promising tool for auxiliary diagnosis and prognostic assessment in bladder cancer.CONCLUSION
The developed ddPCR assay enables accurate and reliable quantification of FRS2 copy number in FFPE samples, offering a promising tool for auxiliary diagnosis and prognostic assessment in bladder cancer.Details
Subject
MeSH
Humans, In Situ Hybridization, Fluorescence, Cell Line, Tumor, Reproducibility of Results, Male, Urinary Bladder Neoplasms -- genetics (major), Urinary Bladder Neoplasms -- pathology (major), Urinary Bladder Neoplasms -- diagnosis (major), Gene Dosage (major), Polymerase Chain Reaction -- methods (major), Adaptor Proteins, Signal Transducing -- genetics (major), Membrane Proteins -- genetics (major)
Identifier / keyword
Supplemental data
Declarations. Ethics approval and consent to participate: Ethical approval for this study was obtained from the Research Ethics Committee of Shenzhen Luohu People’s Hospital. Written informed consent to participate was obtained from all participants. The study was conducted in accordance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests., Indexing method: Automated
Sponsor
Title
Droplet digital PCR assay for precise determination of FRS2 gene copy number in bladder cancer
Author
Li, Jinqian 1 ; Liang, Jiaqi 2 ; Xu, Yinyan 3 ; Tan, Wei 3 ; Chen, Guanzheng 3 ; Ou, Tong 4
1 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China; NHC Key Laboratory of Tropical Disease Control, School of Tropical Medicine, Hainan Medical University, Haikou, Hainan, 571199, China
2 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China; Luohu Clinical College, Shantou University Medical College, Shenzhen, Guangdong, 518000, China
3 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China
4 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China; Luohu Clinical College, Shantou University Medical College, Shenzhen, Guangdong, 518000, China; Medical Laboratory Center, Shenzhen Luohu Hospital Group, Shenzhen, Guangdong, 518000, China [email protected]
1 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China; NHC Key Laboratory of Tropical Disease Control, School of Tropical Medicine, Hainan Medical University, Haikou, Hainan, 571199, China
2 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China; Luohu Clinical College, Shantou University Medical College, Shenzhen, Guangdong, 518000, China
3 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China
4 Medical Laboratory, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong, 518000, China; Luohu Clinical College, Shantou University Medical College, Shenzhen, Guangdong, 518000, China; Medical Laboratory Center, Shenzhen Luohu Hospital Group, Shenzhen, Guangdong, 518000, China [email protected]
Correspondence author
Author e-mail address
Journal abbreviation
BMC Cancer
Grant
82260400. The National Natural Science Foundation of China.
2022A1515220005. Basic and Applied Basic Research Foundation of Guangdong Province.
JCYJ20210324121613037. The Shenzhen Science and Technology Program.
SZXK054. The Shenzhen Key Medical Discipline Construction Fund.
Volume
25
Issue
1
Pages
1211
Publication year
2025
Country of publication
ENGLAND
eISSN
1471-2407
Source type
Scholarly Journal
Peer reviewed
Yes
Format availability
Internet
Language of publication
English
Document type
Journal Article
Publication history
Online publication date
2025-07-24
Publication note
Electronic
Publication history
First posting date
24 Jul 2025
Accepted date
25 Jul 2025
Revised date
29 Jul 2025
29 Jul 2025
First submitted date
24 Jul 2025
Accession number
40707918
ProQuest document ID
3233257973
Document URL
https://www.proquest.com/scholarly-journals/droplet-digital-pcr-assay-precise-determination/docview/3233257973/se-2?accountid=208611
Copyright
© 2025. The Author(s).
Last updated
2025-07-29
Database
ProQuest One Academic